Human Mars Entry, Descent and Landing Architecture Study: Deployable Decelerators

NASAs Entry, Descent and Landing Architecture Study uses a trajectory simulation framework to evaluate various technologies and concepts of operations for human scale EDL at Mars. The study results inform agency technology investments. This paper summarizes the design assumptions and analysis of two deployable entry concepts performed in Phase 2 of the study. The entry concepts include a rigid deployable called the Adaptable Deployable Entry Placement Technology and an inflatable concept called the Hypersonic Inflatable Aerodynamic Decelerator. This paper describes the concept operations of these vehicles to deliver a 20-metric ton payload to the surface of Mars. Details of vehicle design and flight performance are summarized along with results of analysis on the aft body heating and its effect on the payload. Finally, recommended technology investments based on the results are presented

Near Earth Object (NEO) Mitigation Options Using Exploration Technologies

This work documents the advancements in MSFC threat modeling and mitigation technology research completed since our last major publication in this field. Most of the work enclosed here are refinements of our work documented in NASA TP-2004-213089. Very long development times from start of funding (10-20 years) can be expected for any mitigation system which suggests that delaying consideration of mitigation technologies could leave the Earth in an unprotected state for a significant period of time. Fortunately there is the potential for strong synergy between architecture requirements for some threat mitigators and crewed deep space exploration. Thus planetary defense has the potential to be integrated into the current U.S. space exploration effort. The number of possible options available for protection against the NEO threat was too numerous for them to all be addressed within the study; instead, a representative selection were modeled and evaluated. A summary of the major lessons learned during this study is presented, as are recommendations for future work

A Cryogenic Propellant Production Depot for Low Earth Orbit

The cost of access to space beyond low Earth orbit can be lowered if vehicles can refuel in orbit. The power requirements for a propellant depot that electrolyzes water and stores cryogenic oxygen and hydrogen can be met using technology developed for space solar power. A propellant depot is described that will be deployed in a 400 km circular equatorial orbit, receive tanks of water launched into a lower orbit from Earth by gun launch or reusable launch vehicle, convert the water to liquid hydrogen and oxygen, and store Lip to 500 metric tonnes of cryogenic propellants. The propellant stored in the depot can support transportation from low Earth orbit to geostationary Earth orbit, the Moon, LaGrange points, Mars, etc. The tanks are configured in an inline gravity-gradient configuration to minimize drag and settle the propellant. Temperatures can be maintained by body-mounted radiators; these will also provide some shielding against orbital debris. Power is supplied by a pair of solar arrays mounted perpendicular to the orbital plane, which rotate once per orbit to track the Sun. In the longer term, cryogenic propellant production technology can be applied to a larger LEO depot, as well as to the use of lunar water resources at a similar depot elsewhere

Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition

PI3Kδ is a lipid kinase and a member of a larger family of enzymes, PI3K class IA­(α, β, δ) and IB (γ), which catalyze the phosphorylation of PIP2 to PIP3. PI3Kδ is mainly expressed in leukocytes, where it plays a critical, nonredundant role in B cell receptor mediated signaling and provides an attractive opportunity to treat diseases where B cell activity is essential, e.g., rheumatoid arthritis. We report the discovery of novel, potent, and selective PI3Kδ inhibitors and describe a structural hypothesis for isoform (α, β, γ) selectivity gained from interactions in the affinity pocket. The critical component of our initial pharmacophore for isoform selectivity was strongly associated with CYP3A4 time-dependent inhibition (TDI). We describe a variety of strategies and methods for monitoring and attenuating TDI. Ultimately, a structure-based design approach was employed to identify a suitable structural replacement for further optimization